ARPO Research and Charts

ARPO - Aerpio Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2021-11-14 (Delayed quote data 2025-05-01)

Last 1.67	Change ⇑ +0.19 (+12.84%)	Volume 1,455,565
	Open 1.48	High 1.67	Low 1.44

8EMA (Daily) 1.54	40EMA (Daily) 1.80	50EMA (Daily) 1.89	STO (Daily) 31.579	MACD Hist (Daily) 0.049
8EMA (Weekly) 1.789	40EMA (Weekly) 2.28	50EMA (Weekly) 2.43	STO (Weekly) 6.848	MACD Hist (Weekly) -0.219


Company Profile
Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product razuprotafib is a small molecule Tie2 activator being developed for the topical ocular treatment of primary open-angle glaucoma. Other products under the pipeline are ARP-1536 and AKB-4924.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.